| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 46.351 | 80.773 | 81.407 | 80.126 | 90.859 | 113.908 | 130.402 |
| Total Income - EUR | - | - | - | 46.352 | 80.775 | 81.409 | 80.128 | 90.865 | 113.914 | 130.895 |
| Total Expenses - EUR | - | - | - | 15.631 | 26.548 | 20.276 | 18.346 | 23.086 | 22.952 | 43.581 |
| Gross Profit/Loss - EUR | - | - | - | 30.721 | 54.227 | 61.133 | 61.782 | 67.779 | 90.962 | 87.314 |
| Net Profit/Loss - EUR | - | - | - | 30.257 | 53.420 | 60.319 | 61.117 | 66.889 | 89.846 | 83.480 |
| Employees | - | - | - | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Vaşadi Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 12.421 | 35.735 | 45.844 | 52.074 | 81.465 | 81.121 | 95.177 |
| Current Assets | - | - | - | 19.346 | 33.691 | 23.184 | 25.390 | 16.451 | 43.808 | 39.354 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 4.681 | 19.725 | 9.610 | 13.474 | 14.499 | 24.801 | 7.818 |
| Cash | - | - | - | 14.665 | 13.966 | 13.573 | 11.916 | 1.952 | 19.008 | 29.023 |
| Shareholders Funds | - | - | - | 30.300 | 65.820 | 62.715 | 71.372 | 66.929 | 89.887 | 83.520 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 1.466 | 3.606 | 6.312 | 6.092 | 30.987 | 35.042 | 34.212 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 16.798 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Vaşadi Med S.r.l.